YAP1-MAML2 fusion proteins play a role as activators of the Hippo pathway in several cancers, including glioblastoma, ovarian carcinoma, head and neck carcinoma, nasopharyngeal carcinoma and skin cancer (Valouev et al., 2014; Picco et al., 2019). Here, MAML2 is linked to cancer.